Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Sarcoma
Study Phase
Phase 3
Study Completion Date
January 2010
NCT00354744Uploaded 05-25-2019
Access via NCI by Request
PDS UID: nci-data-387
Intensive Multi-Agent Therapy, Including Dose-Compressed Cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for Patients With High-Risk Rhabdomyosarcoma
Files: NCT00354744-D2
Data DictionaryNCT00354744-D2-Data-Dictionary.pdf
DATANCT00354744-D2-Dataset.csv
OTHERREADME.pdf
Files: NCT00354744-D1
Data DictionaryNCT00354744-D1-Data-Dictionary.pdf
DATANCT00354744-D1-Dataset.csv
OTHERREADME.pdf